Searched for
COVOVAX DOSES
Current Covid strain mild, SII has produced 5-6 million Covovax doses: Adar PoonawallaIndia has recorded 12,193 fresh Covid-19 cases in a span of 24 hours, with the number of active cases of the infection going up to 67,556, ...- Serum Institute of India restarts manufacturing of COVID-19 vaccine CovishieldReacting to reports of COVID-19 vaccines shortage, he said manufacturers are ready but there has been no demand. "Just as a precaution, at ...
- Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...
- Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsLast month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...
- NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portalThe DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9,...
- SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsThe Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...
- DGCI approves Covid-19 vaccine Covovax as heterologous booster dose"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- Govt panel likely to decide on Covovax as a heterologous booster dose for adults on WednesdayPrakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the D...
- Serum Institute seeks drug regulator's approval for market authorisation of its Covid vaccine as booster dosePrakash Kumar Singh, director, government and regulatory affairs, SII, submitted a market authorisation application for the heterologous bo...
- SII seeks permission for Phase-3 trial of Covovax as booster dose in children aged 2 to 18 yearsIn an application, SII Director for Government and Regulatory Affairs Prakash Kumar Singh has sought permission to conduct the Phase-3, obs...
- SII lowers price of each dose of Covovax jab from Rs 900 to Rs 225India's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 last year and in the 12-17 ...
- SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold in EuropePoonawalla, in an exclusive interview with ANI, said, "We have a stockpile of 200 million doses of Covishield...We've already exported 40 m...
- India's drugs regulator gives nod to phase-3 clinical trial of Covid vaccine CovovaxCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- Covid: Govt panel recommends permission for phase-3 trial of Covovax as booster dose in adultsThe Subject Expert Committee on COVID-19 of the Central Drugs Standard Control Organisation had on Friday recommended giving permission for...
- SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- SII set to export 25 crore Covovax doses for Covax from next monthIndia's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...
- No plan yet to take two new shots in Centre's vaccination driveThe government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...
- Covovax better booster for Covishield-vaccinated people: Dr Shahid Jameel, VirologistIndia is gearing up to tackle a possible third wave of the coronavirus pandemic as the Omicron variant of the virus, which is said to be mu...
Load More
